White, who will remain the executive chairman, will be succeeded
by Chief Operating Officer Robert Ford, the company said on
Wednesday.
White, 64, was instrumental in Abbott's acquisitions of rivals
St. Jude Medical and Alere, as well as the separation of
Abbott's pharmaceutical arm into AbbVie Inc <ABBV.N>.
Abbott's shares have gained more than four-fold during White's
tenure.
Ford was named the chief operating officer last year as part of
a succession plan and has been with the company for 23 years.
(Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva
and Sriraj Kalluvila)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|